Skip to main content
3-D Matrix,Ltd. logo

3-D Matrix,Ltd. — Investor Relations & Filings

Ticker · 7777 ISIN · JP3410730000 T Manufacturing
Open in API
Filings indexed 69 across all filing types
Latest filing 2024-06-13 Regulatory Filings
Country JP Japan
Listing T 7777

About 3-D Matrix,Ltd.

https://3dmatrix.com/

3-D Matrix, Ltd. is a global medical technology company specializing in the development and commercialization of products based on a proprietary self-assembling peptide technology. Originating from research at the Massachusetts Institute of Technology (MIT), this platform creates biocompatible hydrogels used primarily as hemostatic agents to control oozing bleeding during surgical and endoscopic procedures. The company's solutions are applied across various medical specialties, including gastroenterology, cardiac surgery, otolaryngology (ENT), and urology. 3-D Matrix is also advancing its peptide platform to develop new applications in wound healing, regenerative medicine, and drug delivery systems, aiming to provide clinically proven solutions that improve patient outcomes.

Recent filings

Filing Released Lang Actions
臨時報告書
Regulatory Filings Classification · 1% confidence The document is titled "臨時報告書" (Extraordinary Report) and is submitted to the Kanto Local Finance Bureau Director on June 13, 2024. The filing reason explicitly states that it is submitted based on Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act and relevant Cabinet Office Ordinance provisions because an event has occurred that significantly impacts the company's financial condition, operating results, and cash flow. The content details specific financial impacts (exchange gains/losses, interest expenses, special profits/losses like impairment and fraud loss) for both consolidated and non-consolidated results for the fiscal period ending April 2024. This structure—a formal report detailing a significant, non-scheduled event impacting financials—is characteristic of a Japanese Extraordinary Disclosure filing, which corresponds best to the general 'Regulatory Filings' category (RNS) or potentially a specific event-driven report if one existed. Given the provided definitions, RNS (Regulatory Filings) is the most appropriate general category for mandatory, event-driven disclosures that are not standard periodic reports (like 10-K or IR) or specific announcements (like DIV or DIRS). The document length is short (1465 chars), suggesting it is the filing itself, not an announcement of a separate, larger report.
2024-06-13 Japanese
確認書
Report Publication Announcement Classification · 1% confidence The document is extremely short (603 characters) and contains a header structure typical of Japanese regulatory filings, specifically mentioning a '確認書' (Confirmation Document) submitted to the Kanto Local Finance Bureau Director ('関東財務局長') based on Article 24-4-8, Paragraph 1 of the Financial Instruments and Exchange Act. The core content confirms that the President and CFO have verified the appropriateness of the contents of the '訂正報告書' (Correction Report) for the Third Quarter (Q3) of the 20th fiscal period (Nov 1, 2023, to Jan 31, 2024). Since this document is a confirmation/verification statement related to a quarterly report correction, and not the comprehensive quarterly report itself, it fits best under the general 'Regulatory Filings' category (RNS) or potentially an 'Audit Report/Information' (AR) if it were a formal audit sign-off, but given the context of confirming the appropriateness of a *correction* to a quarterly report, RNS is the most appropriate general regulatory fallback, as it is not a standard 10-K, IR, or ER. Given the specific nature of confirming the correctness of a previously filed document, RNS is the safest classification as a miscellaneous regulatory filing.
2024-04-15 Japanese
訂正四半期報告書－第20期第3四半期(2023/11/01－2024/01/31)
Interim / Quarterly Report Classification · 1% confidence The document is a Japanese 'Quarterly Report' (四半期報告書) for 3-D Matrix, Ltd. It contains detailed financial statements, management analysis (MDA), and business performance data for the third quarter of the 20th fiscal period (ending January 31, 2024). It is a comprehensive financial report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-04-15 Japanese
臨時報告書
Regulatory Filings Classification · 1% confidence The document is titled '臨時報告書' (Extraordinary Report) in the header and cites regulations like '金融商品取引法24条の５第４項' (Financial Instruments and Exchange Act Article 24-5, Paragraph 4) and '企業内容等の開示に関する内閣府令' (Cabinet Office Ordinance on Disclosure of Corporate Information). It details specific financial events (exchange rate differences, interest payments, fraud loss) and their impact on the financial results for the third quarter of the fiscal year ending April 2024. This structure strongly indicates a mandatory disclosure filing in Japan for significant events that occur between regular filings. Among the provided codes, 'RNS' (Regulatory Filings) is the most appropriate general category for mandatory, non-standardized regulatory disclosures that don't fit 10-K, IR, or ER. The Japanese equivalent of a 6-K or 8-K often falls under this broad regulatory filing category when a more specific code is unavailable or inappropriate. Given the context of significant, non-routine financial impact disclosure, RNS is the best fit.
2024-03-13 Japanese
確認書
Report Publication Announcement Classification · 1% confidence The document is extremely short (603 characters) and contains a header section typical of Japanese regulatory filings, specifically mentioning a '確認書' (Confirmation Document) submitted to the Kanto Local Finance Bureau Director based on Article 24-4-8, Paragraph 1 of the Financial Instruments and Exchange Act. The core content confirms the appropriateness of the '第20期第３四半期' (20th Fiscal Period, 3rd Quarter) Quarterly Report ('四半期報告書') by the CEO and CFO. Since this document is a confirmation *about* a quarterly report, and not the comprehensive quarterly report itself, it falls under the category of a specific regulatory confirmation or announcement related to periodic reporting. Given the options, this is a specific regulatory filing that confirms the accuracy of a periodic report. While it relates to an 'Interim / Quarterly Report' (IR), the document itself is a formal confirmation ('確認書'). In the context of Japanese filings, these confirmations often accompany the main filing. Since it is a specific regulatory document confirming a quarterly report's accuracy, and not the report itself, it is best classified as a general Regulatory Filing (RNS) or potentially a specific type of Audit/Review document if the confirmation implies a review process. However, since it explicitly confirms the 'Quarterly Report' (which is an IR), and it's a short confirmation document, RNS is the safest general regulatory fallback, but let's re-evaluate against the definitions. It is not an ER (Earnings Release - highlights only), nor a full IR (Interim Report). It is a formal confirmation required by law regarding the quarterly report. Given the lack of a specific 'Quarterly Report Confirmation' code, and its nature as a formal regulatory submission, RNS is appropriate, but if we must choose the closest substantive category, it relates directly to the IR. Since it's a confirmation document, and not the report itself, RNS is the most appropriate fallback for a specific regulatory confirmation that isn't explicitly defined elsewhere.
2024-03-13 Japanese
四半期報告書－第20期第3四半期(2023/11/01－2024/01/31)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (四半期報告書) filed under the Financial Instruments and Exchange Act of Japan. It contains detailed financial statements, management analysis (MDA), and business updates for the third quarter of the 20th fiscal period (ending January 31, 2024). It is a comprehensive financial report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-03-13 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.